La cadena de opciones muestra datos clave de las opciones de acciones de Blue Star Foods a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Blue Star Foods..

Blue Star Foods (OTC:BSFC) Bolsa, Cadena de Opciones

Blue Star Foods

Blue Star Foods Corp is an international seafood company based in Miami. It imports, packages, and sells refrigerated pasteurized crab meat, and other premium seafood products. The company derives revenue from importing blue and red swimming crab meat from Indonesia, Philippines and China and distributing it in the United States and Canada under several premium brand names such as Blue Star, Oceanica, Pacifika, Crab & Go, First Choice, Good Stuff and Coastal Pride Fresh and TOBC steelhead salmon and rainbow trout fingerlings produced under the brand name Little Cedar Falls.. The Company's products are sold in the United States and Canada.

BLUE STAR FOODS CORP by BLUE STAR FOODS CORP.

Blue Star Foods Corp

News

Rumors

Trading Ideas

ASTS

Watching AST SpaceMobile; Traders Circulate Unconfirmed Analyst Note Saying Jeff Bezos (Amazon + Blue Origin) Could Become A Investor Based On A Instagram Post

Wells Fargo analyst Michael Turrin maintains Guidewire Software (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GWRE#NYSE">GWRE</a>) with a Overweight and raises the price target from $220 to $265.

Price Target

Analyst Ratings

GWRE

Wells Fargo Maintains Overweight on Guidewire Software, Raises Price Target to $265

JMP Securities analyst Patrick Walravens reiterates Snowflake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNOW#NYSE">SNOW</a>) with a Market Outperform and maintains $245 price target.

Reiteration

SNOW

JMP Securities Reiterates Market Outperform on Snowflake, Maintains $245 Price Target

Wells Fargo analyst Aaron Rakers maintains Hewlett Packard (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HPE#NYSE">HPE</a>) with a Equal-Weight and raises the price target from $17 to $20.

Wells Fargo Maintains Equal-Weight on Hewlett Packard, Raises Price Target to $20

Sprinklr, Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CXM#NYSE">CXM</a>) stock gained on Wednesday after the company reported&nbsp;<a target="_blank" href="https://www.benzinga.com/pressreleases/25/06/b45767285/sprinklr-announces-first-quarter-fiscal-2026-results" rel="noreferrer noopener">fiscal first-quarter&nbsp;2026</a> results.
The quarterly sales of $205.5 million beat the analyst consensus estimate of $203.3 million, and adjusted EPS of 12 cent beat the <a href="https://www.benzinga.com/calendars/earnings" target="_blank" rel="noreferrer noopener">analyst consensus estimate</a> of $0.10.
Subscription revenue increased 3.8% Y/Y to $184.13 million.
Also Read: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/03/44311026/sprinklrs-fy26-will-be-a-transition-year-with-operational-gains-amid-turnaround-analyst-says" target="_blank" rel="noreferrer noopener">Sprinklr&#8217;s FY26 Will Be A Transition Year With Operational Gains Amid Turnaround, Analyst Says</a>
RPO and cRPO were up&nbsp;2% and 5% Y/Y, respectively, in the quarter.
Adjusted operating income rose to $36.7 million from $20.9 million a year ago, with a margin of 18% versus 11% in the prior-year quarter.
As of April 30, 2025, cash, cash equivalents, and marketable securities stood at $570.2 million. It generated free cash flow of $80.7 million.
Share Buyback: In June 2025, the Board of Directors authorized a new $150 million stock buyback program.
Outlook:&nbsp;Sprinklr expects fiscal 2026 revenue of $825.00 million-$827.00 million (prior 821.50 million-$823.50 million) vs. the consensus estimate of $821.94 million. The company projects subscription revenue of $741 million-$743 million.
The company raised its adjusted EPS to $0.39-$0.40 (prior $0.38-$0.39)&nbsp;versus the $0.38 consensus estimate.
For the second quarter, the company sees revenue of&nbsp;$205.00 million-$206.00 million vs. <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">analyst estimate</a>&nbsp;$207.16 million and adjusted EPS of&nbsp;$0.10 (vs. street view of&nbsp;$0.10). The company projects subscription revenue of $184 million-$185 million.
Price Action: CXM shares are up 4.80% at $8.96 premarket at the last check Wednesday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/large-cap/25/06/45755544/rising-ai-analytics-budgets-could-lift-microsoft-snowflake-datadog" target="_blank" rel="noreferrer noopener">Rising AI, Analytics Budgets Could Lift Microsoft, Snowflake, Datadog</a></li>
</ul>

Earnings

Guidance

Buybacks

Sprinklr Rises On Solid Earnings, Raised Outlook, And New $150 Million Buyback Plan

B of A Securities analyst Allen Lutz maintains HealthEquity (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HQY#NASDAQ">HQY</a>) with a Buy and raises the price target from $110 to $125.

B of A Securities Maintains Buy on HealthEquity, Raises Price Target to $125

Wells Fargo analyst Sam Reid maintains Ferguson Enterprises (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FERG#NYSE">FERG</a>) with a Overweight and raises the price target from $190 to $230.

FERG

Wells Fargo Maintains Overweight on Ferguson Enterprises, Raises Price Target to $230

JMP Securities analyst Reni Benjamin reiterates Kura Oncology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KURA#NASDAQ">KURA</a>) with a Market Outperform and maintains $28 price target.

KURA

JMP Securities Reiterates Market Outperform on Kura Oncology, Maintains $28 Price Target

Wells Fargo analyst Joe O'Dea maintains Johnson Controls Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JCI#NYSE">JCI</a>) with a Overweight and raises the price target from $100 to $130.

Wells Fargo Maintains Overweight on Johnson Controls Intl, Raises Price Target to $130

Wells Fargo analyst Matthew Akers maintains Science Applications Intl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAIC#NASDAQ">SAIC</a>) with a Overweight and raises the price target from $132 to $137.

SAIC

Wells Fargo Maintains Overweight on Science Applications Intl, Raises Price Target to $137

<ul>
<li>CRWV</li>
<li>HOOD</li>
<li>ADP</li>
<li>TSLA</li>
<li>NVDA</li>
<li>GLD</li>
<li>GOOGL</li>
<li>UMH</li>
<li>RDDT</li>
<li>AAPL</li>
</ul>
Data from <a href="https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment">https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment</a>
&nbsp;

AAPL

CRWV

GOOGL

HOOD

NVDA

RDDT

TSLA

Top 10 Trending Stocks On WallStreetBets As Of June 4, 2025 (Via Swaggy Stocks)

JMP Securities analyst Constantine Davides maintains HealthEquity (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HQY#NASDAQ">HQY</a>) with a Market Outperform and raises the price target from $110 to $117.

JMP Securities Maintains Market Outperform on HealthEquity, Raises Price Target to $117

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul class="wp-block-list">
<li>HC Wainwright &amp; Co. analyst Emily Bodnar upgraded the rating for AnaptysBio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANAB#NASDAQ">ANAB</a>) from Neutral to Buy and raised the price target from $22 to $38. AnaptysBio shares closed at $23.52 on Tuesday. <a href="https://www.benzinga.com/quote/ANAB/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Barclays analyst David Anderson upgraded Cactus, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WHD#NYSE">WHD</a>) from Equal-Weight to Overweight and raised the price target from $51 to $54. Cactus shares closed at $44.11 on Tuesday. <a href="https://www.benzinga.com/quote/WHD/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>HSBC analyst Cenk Orcan upgraded the rating for Embraer S.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ERJ#NYSE">ERJ</a>) from Hold to Buy and raises the price target from $45 to $57. Embraer shares closed at $45.99 on Tuesday. <a href="https://www.benzinga.com/quote/ERJ/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Citigroup analyst David Lebowitz upgraded Blueprint Medicines Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BPMC#NASDAQ">BPMC</a>) from Sell to Neutral and raised the price target from $83 to $129. Blueprint Medicines shares closed at $127.60 on Tuesday. <a href="https://www.benzinga.com/quote/BPMC/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>UBS analyst Karl Keirstead upgraded Snowflake Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNOW#NYSE">SNOW</a>) from Neutral to Buy and raised the price target from $210 to $265. Snowflake shares closed at $209.18 on Tuesday. <a href="https://www.benzinga.com/quote/snow/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying SNOW stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><a href="https://www.benzinga.com/quote/SNOW/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="599" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/04093653/image-49-1024x599.png" alt="" class="wp-image-938280" style="width:644px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/04093653/image-49-1024x599.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/04093653/image-49-300x176.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/04093653/image-49-768x450.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/04093653/image-49.png 1112w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/25/06/45762621/cramer-shouldve-told-investors-to-pull-the-trigger-on-trade-desk-cant-believe-how-low-gentex-has-fal">Cramer: Should&#8217;ve Told Investors To &#8216;Pull The Trigger&#8217; On Trade Desk, Can&#8217;t Believe &#8216;How Low&#8217; Gentex Has Fallen</a> </li>
</ul>
Photo via Shutterstock

Upgrades

Markets

ANAB

BPMC

Embraer-Empresa Brasileira De Aeronautica

This Snowflake Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday

Wells Fargo analyst Michael Brown maintains BlackRock (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLK#NYSE">BLK</a>) with a Overweight and raises the price target from $1035 to $1105.

Wells Fargo Maintains Overweight on BlackRock, Raises Price Target to $1105

Dividends

Watching Wells Fargo; Reuters Reports, During CNBC Interview, CEO Charlie Scharf Said Wants To Increase Dividend After Fed Lifts Asset Cap

Biotech

General

SRPT

Sarepta Therapeutics Granted FDA Platform Technology Designation For rAAVrh74 Viral Vector Used In Investigational Gene Therapy SRP-9003 For Treatment Of Limb-Girdle Muscular Dystrophy Type 2E/R4

Wells Fargo analyst Edward Kelly maintains Dollar General (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DG#NYSE">DG</a>) with a Equal-Weight and raises the price target from $80 to $105.

Wells Fargo Maintains Equal-Weight on Dollar General, Raises Price Target to $105

JMP Securities analyst Aaron Kimson maintains Guidewire Software (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GWRE#NYSE">GWRE</a>) with a Market Outperform and raises the price target from $250 to $281.

JMP Securities Maintains Market Outperform on Guidewire Software, Raises Price Target to $281

On June 2, 2025, Jonathan M. Tisch informed Loews Corporation (the "Corporation") that he will retire from his position as Executive Chairman of the Corporation's subsidiary, Loews Hotels Holding Corporation ("Loews Hotels &amp; Co"), effective December 31, 2025. Following his retirement, Mr. Tisch will be available to provide consulting services to Loews Hotels &amp; Co for up to 200 hours per year at an hourly rate.

Management

Loews Hotels & Co Announces Jonathan M. Tisch To Retire As Executive Chairman, Effective December 31, 2025

REV Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/REVG#NYSE">REVG</a>) shares are trading higher after the company reported <a href="https://www.benzinga.com/pressreleases/25/06/b45766706/rev-group-inc-reports-strong-fiscal-2025-second-quarter-results-updates-2025-guidance" target="_blank" rel="noreferrer noopener">second-quarter FY25 results</a>.
Net sales of $629.1 million beat the consensus of $612 million.
Excluding the impact of bus manufacturing, total net sales increased 7.7% Y/Y, aided by growth of the Specialty Vehicles segment.
Specialty Vehicles segment net sales rose 3.8% year over year (Y/Y) to $453.9 million, while Recreational Vehicles segment net sales declined&nbsp;2.4% Y/Y to $175.3&nbsp;million.
At the end of the second quarter of 2025, the specialty vehicles segment&#8217;s backlog stood at $ 4.28 billion, and the recreational vehicles segment&#8217;s backlog came in at $ 267.9 million.
Adjusted EBITDA stood at $58.9 million versus $37.5 million a year ago. Adjusted EPS of 70 cents exceeded the <a href="https://www.benzinga.com/earnings" target="_blank" rel="noreferrer noopener">street view of 62 cents</a>.
As of April 30, net debt totaled $101.2 million, with $28.8 million cash on hand.
Dividend: The board disclosed its regular quarterly cash dividend per share of 6 cents, payable on July 11 to shareholders of record on June 27.
Buyback: In the quarter,&nbsp;the company repurchased around 2.9&nbsp;million of its shares for&nbsp;$88.4&nbsp;million.&nbsp;
As of April 30, the company had shares worth approximately $142.4 million remaining under the current repurchase program. 
Outlook&nbsp;Revised:&nbsp;REV Group updated FY25 guidance for&nbsp;net sales to&nbsp;$2.35 billion-$2.45 billion <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">(vs.&nbsp;$2.3 billion&nbsp;–&nbsp;$2.4 billion)</a> compared to an estimate of&nbsp;$2.38 billion and the adjusted&nbsp;net income to $112 million-$130 million <a target="_blank" href="https://www.benzinga.com//node/44139817" rel="noreferrer noopener">(from&nbsp;$116 million&nbsp;–&nbsp;$140 million prior)</a>.
REV CEO Mark Skonieczny said the company plans &#8220;to accelerate certain capital investments to further our manufacturing throughput goals including a $20 million investment in our Brandon, South Dakota location.&#8221;
&#8221;Today we are updating our full year fiscal guidance with an expectation that year-to-date performance and sustained operational excellence provide a foundation to offset the potential impacts from tariffs.&#8221;
Price Action: REVG shares are up&nbsp;6.88%&nbsp;at&nbsp;$39.78 premarket at the last check Wednesday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com//node/45755663" target="_blank" rel="noreferrer noopener">BofA Securities Stays Bullish On Caterpillar: &#8216;Surprisingly Durable&#8217; US Economy, Global Momentum</a></li>
</ul>

Comments

Blue Star Foods

Blue Star Foods (BSFC) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL